Kaplan–Meier analysis based on the median cutoff value revealed that patients with high DAB2IP mRNA expression in ccRCC had an increased overall survival time compared to patients with low mRNA expression levels of the 532 patients in the TCGA dataset (log-rank test p =4.9×10−6, HR [95%CI]: 0.47 [0.34-0.66], Figure 5C). The gene discussed is DAB2IP; the disease is nonpapillary renal cell carcinoma.